Agencies and Commissions November 3, 2005 – Federal Register Recent Federal Regulation Documents

The U.S. Small Business Administration (SBA) is considering granting a waiver of the Nonmanufacturer Rule for Forklifts Manufacturing. The basis of waivers is that no small business manufacturers are supplying these classes of products to the Federal government. The effect of a waiver would be to allow otherwise qualified regular dealers to supply the products of any domestic manufacturer on a Federal contract set aside for small businesses, service-disabled veteran-owned small businesses, or SBA's 8(a) Business Development Program to provide the products of small business manufacturers or processors on such contracts. The purpose of this notice is to solicit comments and potential source information from interested parties.

This is an amendment of the Presidential declaration of a major disaster for the State of Florida (FEMA-1609-DR), dated 10/24/ 2005. Incident: Hurricane Wilma. Incident Period: 10/23/2005 and continuing. Effective Date: 10/26/2005. Physical Loan Application Deadline Date: 12/23/2005. EIDL Loan Application Deadline Date: 07/24/2006.

This is a Notice of the Presidential declaration of a major disaster for the State of Florida (FEMA-1609-DR), dated October 24, 2005. Incident: Hurricane Wilma. Incident Period: October 23, 2005 and continuing. Effective Date: October 24, 2005. Physical Loan Application Deadline Date: December 23, 2005. EIDL Loan Application Deadline Date: July 24, 2006.

The Commission hereby gives notice that it has instituted this proceeding following receipt on October 14, 2005, of a request from the United States Trade Representative (USTR) for a determination under section 129(a)(4) of the URAA that would render the Commission's action in connection with Investigation No. 701-TA-431 not inconsistent with the findings of the dispute settlement panel of the World Trade Organization (WTO) in its report United StatesCountervailing Duty Investigation on Dynamic Random Access Memory Semiconductors (DRAMs) from Korea, WT/DS296/R. For further information concerning the conduct of this proceeding and rules of general application, consult the Commission's Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subpart A (19 CFR part 207).

This Notice of Proposed Rulemaking (NPRM) proposes to delete in its entirety of the Legal Services Corporation's regulation at 45 CFR part 1631, Expenditure of Grant Funds. The proposed deletion is warranted because the statutory authority for part 1631 is no longer the prevailing rule of law.

The Institute of Museum and Library Service as part of its continuing effort to reduce paperwork and respondent burden, conducts a pre-clearance consultation program to provide the general public and federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (PRA95)[44 U.S.C. 3508(2)(A)]. This program helps to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. Currently the Institute of Museum and Library Services is soliciting comments concerning the collection of information to assist IMLS understand the information needs and expectations of users and potential users of online information including, but not limited to information currently available online through libraries, museums and other cultural heritage institutions, and the Internet, and of the impacts of having such information. A copy of the proposed information collection request can be obtained by contacting the individual listed below in the addressee section of this notice.

This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in U.S. Patent Nos. 5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 5,153,132, entitled ``Three-Dimensional Co-culture Process''; 5,153,133, entitled ``Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled ``Three Dimensional Cell to Tissue Assembly Process''; 5,155,035, entitled `` Method for Culturing Mammalian Cells in a Perfused Bioreactor''; 5,308,764, entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 5,496,722, entitled ``Method for Producing Non-neoplastic, Three- dimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom''; 5,627,021, entitled ``Three- Dimensional Co-Culture Process''; 5,637,477, entitled ``Recombinant Protein Production and Insect Cell Culture and Process''; 5,846,807, entitled ``Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions''; 5,851,816, entitled ``Cultured High-Fidelity Three-Dimensional Human Urogenital Tract Carcinomas and Process''; 5,858,783, entitled ``Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 5,962,324, entitled ``Three Dimensional Optic Tissue Culture and Process''; 6,177,674, entitled ``Pathogen Propagation in Cultured Three-Dimensional Tissue Mass''; 6,485,963, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity''; 6,946,246, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and U.S. Patent Application Serial Number 10/734,759, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', U.S. Patent Application Serial Number 10/947,786, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.